Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-08

FDA Approved: GLATOPA — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for GLATOPA (glatiramer acetate) from Sandoz Inc, providing a generic version of glatiramer acetate. The approval co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATOPA (GLATIRAMER ACETATE)

Snippet

SUPPL AP for GLATOPA (GLATIRAMER ACETATE)